Position history for FARALLON CAPITAL MANAGEMENT LLC's holdings in AGIOS PHARMACEUTICALS INC
FARALLON CAPITAL MANAGEMENT LLC holds 5.7M shares of AGIO (AGIOS PHARMACEUTICALS INC), worth $192.3M as of 2026-Q1. The position was increased (+10.2% shares). AGIO represents 1.1% of FARALLON CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$192.3M
Current Shares
5.7M
Total Value Change
-$51.5M
Total Shares Change
+29,498
Other major holders of AGIO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BNP PARIBAS FINANCIAL MARKETS
Increased |
| 5.7M |
+10.2% |
| $192.3M |
| 1.1% |
| $28.48 |
53 |
| 2025-Q4 | Decreased | 5.2M | -10.8% | $140.4M | 0.7% | $27.33 | 0 |
| 2025-Q3 | Increased | 5.8M | +0.2% | $232.1M | 0.9% | $39.27 | 43 |
| 2025-Q2 | Increased | 5.8M | +1.2% | $191.8M | 0.8% | $33.47 | 43 |
| 2025-Q1 | Increased | 5.7M | +0.5% | $167M | 0.9% | $30.28 | 43 |
| 2024-Q4 | Increased | 5.7M | +0.2% | $186.5M | 0.9% | $33.03 | 43 |
| 2024-Q3 | Increased | 5.7M | +0.1% | $251.5M | 1.2% | $45.61 | 48 |
| 2024-Q2 | Increased | 5.7M | +1.1% | $243.8M | 1.2% | $43.12 | 49 |